Comparison of neointimal coverage between ultrathin biodegradable polymer-coated sirolimus-eluting stents and durable polymer-coated everolimus-eluting stents: 6 months optical coherence tomography follow-up from the TAXCO study

被引:13
|
作者
Abhyankar, Atul [1 ]
Abizaid, Alexandre [2 ]
Chamie, Daniel [3 ]
Rathod, Mihir [1 ]
机构
[1] Shree BD Mehta Mahavir Heart Inst, Dept Cardiol, Surat, Gujarat, India
[2] Univ Sao Paulo, Intervent Cardiol Dept, Sao Paulo, Brazil
[3] Dante Pazzanese Inst Cardiol, Invas Cardiol Dept, Sao Paulo, Brazil
关键词
coronary artery disease; drug-eluting stent; everolimus; percutaneous coronary intervention; sirolimus; PERCUTANEOUS CORONARY INTERVENTION; VASCULAR-RESPONSE; STRUT THICKNESS; THROMBOSIS; ANGIOGRAPHY; MECHANISMS; PATHOLOGY; IMPACT; RISK;
D O I
10.1002/ccd.28833
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim The TAXCO study was designed to compare the degree of neointimal coverage and the prevalence of malapposition at 6 months subsequent to implantation of ultrathin biodegradable polymer-coated sirolimus-eluting stents (SES) and durable polymer-coated everolimus-eluting stents (EES) of thin strut thickness using optical coherence tomography (OCT). Methods The TAXCO study included a total of 42 patients who gave consent and underwent OCT examination between August 2017 and September 2017. Of 42, five patients' OCT examinations were of insufficient quality for quantitative analysis. Thus, the OCT analysis group consisted of 37 patients. Among them, 16 patients were treated with Xience (Abbott Vascular) and 21 with Tetriflex (Sahajanand Medical Technologies Pvt. Ltd., Surat, India), 6 (+/- 1) months earlier at our institution. The OCT was performed using a C7 Dragonfly (TM) imaging catheter (St. Jude Medical Inc.). All OCT images were analyzed at an independent core laboratory (Cardiovascular Research Center, Sao Paulo, Brazil) by analysts who were blinded to patient and procedural information. Results A total of 763 crosssections (6,882 struts) were analyzed in Xience group, and 1,127 crosssections (9,968 struts) in Tetriflex group. At 6 months, on per-lesion basis, no significant differences were observed between Xience group and Tetriflex group in mean percentage of uncovered struts (1.87 +/- 3.86 vs. 2.42 +/- 3.46, p = .137) and malapposed struts (0.05 +/- 0.2 vs. 0.21 +/- 0.69, p = .302). Strut-level neointimal thickness also did not differ between Xience group and Tetriflex group (0.18 +/- 0.12 vs. 0.14 +/- 0.08 mm, p = .286). Conclusion This OCT study found no significant difference in strut coverage and neointimal thickness at 6 months after implantation of biodegradable polymer-coated Tetriflex, when compared with durable polymer-coated Xience.
引用
收藏
页码:423 / 430
页数:8
相关论文
共 50 条
  • [41] Optical coherence tomography findings: insights from the "randomised multicentre trial investigating angiographic outcomes of hybrid sirolimus-eluting stents with biodegradable polymer compared with everolimus-eluting stents with durable polymer in chronic total occlusions" (PRISON IV) trial
    Teenwen, Koen
    Spoormans, Eva M.
    Bennett, Johan
    Dubois, Christophe
    Desmet, Walter
    Ughi, Giovanni J.
    Belmans, Ann
    Kelder, Johannes C.
    Tijssen, Jan G. P.
    Agostoni, Pierfrancesco
    Suttorp, Marrten J.
    Adriaenssens, Tom
    EUROINTERVENTION, 2017, 13 (05) : 522 - 530
  • [42] Randomized comparison of biolimus-eluting stents with biodegradable polymer versus everolimus-eluting stents with permanent polymer coatings assessed by optical coherence tomography
    Tomohisa Tada
    Adnan Kastrati
    Robert A. Byrne
    Tibor Schuster
    Rezarta Cuni
    Lamin A. King
    Salvatore Cassese
    Michael Joner
    Jürgen Pache
    Steffen Massberg
    Albert Schömig
    Julinda Mehilli
    The International Journal of Cardiovascular Imaging, 2014, 30 : 495 - 504
  • [43] Biodegradable-Polymer Biolimus-Eluting Stents versus Durable-Polymer Everolimus-Eluting Stents at One-Year Follow-Up: A Registry-Based Cohort Study
    Parsa, Ehsan
    Saroukhani, Sepideh
    Majlessi, Fereshteh
    Poorhosseini, Hamidreza
    Lofti-Tokaldany, Masoumeh
    Jalali, Arash
    Salarifar, Mojtaba
    Nematipour, Ebrahim
    Alidoosti, Mohammad
    Aghajani, Hassan
    Amirzadegan, Alireza
    Kassaian, Seyed Ebrahim
    TEXAS HEART INSTITUTE JOURNAL, 2016, 43 (02): : 126 - 130
  • [44] Ultrathin, biodegradable polymer-coated everolimus-eluting stents for patients undergoing percutaneous coronary intervention: Final three-year results of the PERFORM-EVER registry
    Kasturi, Sridhar
    Polasa, Srinivas
    Sowdagar, Mohammad Ali
    Kumar, Praveen
    Reddy, Thejanandan
    Nichenamatla, Chaitanya
    Singh, Shailender
    Reddy, Vijay Kumar
    INDIAN HEART JOURNAL, 2023, 75 (06) : 469 - 472
  • [45] Comparison of efficacy and safety between ultrathin bioresorbable polymer sirolimus-eluting stents and thin durable polymer drug-eluting stents: a systematic review and meta-analysis of the literature
    Zhai, Zhen-yu
    Li, Ju-xiang
    CORONARY ARTERY DISEASE, 2019, 30 (08) : 590 - 599
  • [46] Three-Year Outcomes of Biodegradable Polymer-Coated Ultra-Thin (60 μm) Sirolimus-Eluting Stents in Real-World Clinical Practice
    Chandwani, Prakash
    Meel, Bhavesh
    Sinahal, Rahul
    Jangid, Kushal
    Ahmed, Rasheed
    Yadav, Mukesh
    Gupta, Anshul Kumar
    Chopra, Rohit
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2019, 48 (05) : 150 - 155
  • [47] Comparison of neointimal coverage between durable-polymer everolimus-eluting stents and bioresorbable-polymer everolimus-eluting stents 1 year after implantation using high-resolution coronary angioscopy
    Nojima, Yuhei
    Adachi, Hidenori
    Ihara, Madoka
    Kurimoto, Tetsuya
    Okayama, Keita
    Sakata, Yasushi
    Nanto, Shinsuke
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2019, 94 (02) : 204 - 209
  • [48] Randomized comparison of novel biodegradable polymer and durable polymer-coated cobalt-chromium sirolimus-eluting stents: Three-Year Outcomes of the I-LOVE-IT 2 Trial
    Song, Lei
    Li, Jing
    Guan, Changdong
    Jing, Quanmin
    Lu, Shuzheng
    Yang, Lixia
    Xu, Kai
    Yang, Yuejin
    Xu, Bo
    Han, Yaling
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2018, 91 : 608 - 616
  • [49] Comparison of very early-phase vascular response to the CD34 antibody-covered sirolimus-eluting stent versus durable polymer-coated everolimus-eluting stent
    Goto, Hiroki
    Kitahara, Hideki
    Matsumoto, Tadahiro
    Tateishi, Kazuya
    Saito, Yuichi
    Kato, Ken
    Kobayashi, Yoshio
    CARDIOVASCULAR INTERVENTION AND THERAPEUTICS, 2025,
  • [50] Optical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: comparison with sirolimus-eluting stents
    Kim, J-S
    Jang, I-K
    Kim, J-S
    Kim, T. H.
    Takano, M.
    Kume, T.
    Hur, N. W.
    Ko, Y-G
    Choi, D.
    Hong, M-K
    Jang, Y.
    HEART, 2009, 95 (23) : 1907 - 1912